GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. "We are extremely excited to welcome Clay Schwabe to the executive team at Precision Optics," stated Dr. Joe Forkey, CEO of Precision Optics. "Clay's entrepreneurial mindset and experience developin ...

GARDNER, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice President of Sales and Marketing. Mr. Schwabe has over fifteen years of experience in medical device market access, sales, sales management, global product marketing, and commercialization. He is an emerging technologies specialist ...

GARDNER, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company Webcast The webcasted presentation will ...

财务数据和关键指标变化 - 第三季度总收入为5.24百万美元,接近公司历史最高季度收入5.29百万美元(不包括上一年度第二季度的一次性技术许可收入) [11][12] - 工程收入创纪录达2.3百万美元,同比增长62% [36] - 生产收入为3百万美元,同比下降16.7% [36][37] - 毛利率为35.4%,同比提升1个百分点,环比提升5.3个百分点 [38] - 经营亏损收窄至258,000美元,同比改善235,000美元 [39] - 调整后EBITDA为52,000美元,同比改善43,000美元,环比改善321,000美元 [40] 各条业务线数据和关键指标变化 - 医疗设备业务:公司获得一笔9百万美元的大单,用于为客户的膀胱镜手术系统供应一次性内窥镜组件 [15][16][17][19] - 航空航天和国防业务: - 获得一笔720,000美元的后续生产订单,该订单与一家顶级国防航天公司的高精密微光学系统相关 [23] - 获得一笔125万美元的订单,用于满足一家主要美国国防承包商对一种复杂光学组件的持续需求 [24][25] 各个市场数据和关键指标变化 - 医疗设备市场:单次使用内窥镜市场正以2-3倍于整体内窥镜市场的速度增长 [21] - 航空航天和国防市场:公司正在加大对该市场的开拓力度,看到了对小型光学系统的需求,符合行业对尺寸、重量和功耗的要求 [26][27] 公司战略和发展方向及行业竞争 - 公司正在更新营销方法,为医疗设备客户提供基线设计,加快客户的上市时间,提高竞争优势 [28][29][30] - 公司正在整合生产设施和管理团队,提高运营效率,为未来收入增长和利润改善做好准备 [14][45][46] - 公司正在加强对航空航天和国防市场的开拓,看到了更多机会 [26][27] 管理层对经营环境和未来前景的评论 - 公司业务处于有史以来最好的位置,工程管线创历史新高,多个产品即将或已转入生产 [44][45][46] - 预计未来几年收入和利润将持续增长,单次使用内窥镜订单的获得是一个重要里程碑 [31][32][33] 问答环节重要的提问和回答 问题1 **Robert Blum 提问** 公司是否需要扩大生产设施以满足新订单的需求 [50] **Joe Forkey 回答** 公司正在采取措施灵活调整生产空间,包括搬迁到更小的设施以及利用现有的四个设施进行调整,以满足短期和长期的生产需求 [51][52] 问题2 **Robert Blum 提问** 公司如何在为客户提供加速上市的平台系统的同时,保持对核心技术的知识产权控制 [53] **Joe Forkey 回答** 公司通过区分客户关键竞争优势所在的知识产权和公司核心微光学成像技术的知识产权,与客户进行多轮谈判,最终达成双方可接受的知识产权分配方案 [54] 问题3 **Robert Blum 提问** 公司对第四季度的收入前景有何展望 [58] **Joe Forkey 回答** 公司预计第四季度收入将与第三季度持平或有所增长,具体取决于一些新项目何时能达到更高的产量 [60]

or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-10647 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 PRECISION OPTICS CORPORATION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

Company Participants Conference Call Participants Operator Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners. Please go ahead. All right. Thank you, Andrea, and to everyone as well for joining the call today. As the operator mentioned on today's call, we will discuss Precision Optics' second quarter fiscal year 2024 financial results for the period ended December 31, 2023. Today's conference call is also being webcast with replay capabi ...

Table of Contents Commission File Number: 001-10647 PRECISION OPTICS CORPORATION, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Exact name of registrant as specified in its charter) (State or other juris ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 For the transition period from to Commission File Number: 001-10647 PRECISION OPTICS CORPORATION, INC. (Exact name of registrant as specified in its charter) Massachusetts 04-2795294 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identific ...

Hold on just a moment, Anthony. I believe we have perhaps one question just came in. Our next -- our question will come from [Norman Kadajian], a private investor. Precision Optics Corporation, Inc. (NASDAQ:POCI) Q1 2024 Results Conference Call November 9, 2023 5:00 PM ET Yes, sure. So the way I think about this is that this is really the long tail of COVID. And I know everyone's sick of hearing about COVID, but it still persists a little bit when it comes to some of the impacts on the business. The way we ...

Robert Blum - Lytham Partners, LLC Joseph Forkey - President and Chief Executive Officer Wayne Coll - Chief Financial Officer I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead. Company Participants Operator Robert Blum With us on the call representing the company today are Dr. Joe Forkey, Precision Optics' President and Chief Executive Officer; and Wayne Coll, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we'll open the ...